Expression of concern reaffirmed
- PMID: 16495386
- DOI: 10.1056/NEJMe068054
Expression of concern reaffirmed
Comment in
-
Response to expression of concern regarding VIGOR study.N Engl J Med. 2006 Mar 16;354(11):1196-9. doi: 10.1056/NEJMc066096. Epub 2006 Feb 22. N Engl J Med. 2006. PMID: 16495387 No abstract available.
Comment on
-
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group.N Engl J Med. 2000 Nov 23;343(21):1520-8, 2 p following 1528. doi: 10.1056/NEJM200011233432103. N Engl J Med. 2000. PMID: 11087881 Clinical Trial.
-
Expression of concern: Bombardier et al., "Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis," N Engl J Med 2000;343:1520-8.N Engl J Med. 2005 Dec 29;353(26):2813-4. doi: 10.1056/NEJMe058314. Epub 2005 Dec 8. N Engl J Med. 2005. PMID: 16339408 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical